Nexalin Technology Awarded Key Deep-Brain Stimulation Device Patent

June 20, 2024

DENVER, Colo., Jun 20, 2024 (247marketnews.com)- Nexalin Technology, Inc. (Nasdaq:NXL) reported that the United States Patent and Trademark Office (USPTO) awarded U.S. Patent No 12,011,591 relating to the Company’s non-invasive Deep Intracranial Frequency Stimulation medical device for the treatment of Alzheimer’s and other dementia-related brain diseases, entitled “Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method for Alzheimer’s and Dementia”.

Nexalin Technology’s CEO, Mark White, commented, “The award of this patent marks another major milestone for the Company, as we expand our intellectual property to include the treatment of Alzheimer’s and dementia.  According to Grandview Research, the global dementia treatment market is estimated to be in excess of $18 billion and is projected to reach over $28 billion by 2030.  This growth is driven by the increasing prevalence of various forms of dementia.  According to the World Health Organization, more than 55 million people currently live with dementia and nearly 10 million new cases are diagnosed every year.  The market is further bolstered by significant investments in research and development.  According to the Alzheimer’s Association, annual funding for Alzheimer’s and dementia research by the federal government is estimated to be in excess of $3 billion annually, which underscores the critical need for innovative treatments like Nexalin’s neurostimulation device.  Our growing body of published clinical studies supports the clinical benefits of our device for the treatment of a variety of neurological diseases associated with deep brain structures, ranging from treatment-resistant depression to migraines, anxiety, insomnia, addiction and PTSD.  Similarly, we believe that our DIFS® technology holds the potential to revolutionize the standard of care for additional mental health disorders such as Alzheimer’s and dementia.”

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (NXL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.